NIH-45-46-G-54-W

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameNIH-45-46-G-54-W
Drug Alias NameNIH-45-46-G-54-WNIH45-46-G54W
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEnvelope glycoprotein gp160 inhibitorsAnti-CD4
TargetsT-cell surface antigen CD4Envelope glycoprotein gp160
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCalifornia Institute Of Technology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCalifornia Institute Of Technology
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A